title: Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease.
authors.affiliation: Institute of Pathology, University of Basel, Switzerland.
authors.forename: Philip
authors.initials: P
authors.lastname: Went
authors.forename: Stefano
authors.initials: S
authors.lastname: Ascani
authors.forename: Erik
authors.initials: E
authors.lastname: Strøm
authors.forename: Sverre-Henning
authors.initials: SH
authors.lastname: Brorson
authors.forename: Maurizio
authors.initials: M
authors.lastname: Musso
authors.forename: Pier-Luigi
authors.initials: PL
authors.lastname: Zinzani
authors.forename: Brunangelo
authors.initials: B
authors.lastname: Falini
authors.forename: Stephan
authors.initials: S
authors.lastname: Dirnhofer
authors.forename: Stefano
authors.initials: S
authors.lastname: Pileri
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001707:Biopsy, Needle; D033941:Clathrin Light Chains / Q000378:metabolism; D005260:Female; D005500:Follow-Up Studies; D006362:Heavy Chain Disease / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D008198:Lymph Nodes / Q000473:pathology*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D008875:Middle Aged; D018570:Risk Assessment
chemical_list: D033941:Clathrin Light Chains